Science Mourns Gregory Hannon, Pioneer of RNA Silencing and Cancer Genomics

Gregory J. Hannon was among the most influential molecular biologists of his generation, and his passing in 2026 marks a profound loss for the biomedical sciences. This tribute, published in Cell by close collaborators Julius Brennecke and Scott Lowe, honors his extraordinary contributions to gene regulation, genome stability, and cancer biology.

Hannon's early career produced seminal insights into RNA interference, a mechanism by which small RNA molecules silence gene expression. His laboratory was instrumental in demonstrating RNAi's power as both a biological regulatory system and an experimental tool, catalyzing an entire era of functional genomics research that continues today.

Perhaps his most celebrated later work concerned piRNAs — small non-coding RNAs that suppress transposable elements in the germline. By showing how piRNA pathways defend genome integrity across generations, Hannon connected RNA biology to fundamental questions of heredity, aging, and evolutionary stability. This work has direct relevance to longevity research, as transposon derepression is increasingly recognized as a driver of cellular aging.

Hannon also co-led efforts to develop spatial transcriptomics and single-cell sequencing approaches, technologies now widely used to map tumor heterogeneity and understand the cellular ecosystems driving cancer progression. His translational vision helped bridge molecular discovery and clinical oncology.

The tribute does not present new experimental findings but rather synthesizes Hannon's intellectual arc and lasting influence. For longevity and cancer researchers, his body of work provides foundational frameworks — from genome surveillance to single-cell resolution of disease — that will guide investigation for decades. The loss of such a generative scientific mind is itself a reminder of the urgency driving longevity science.